CoreCap Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

CoreCap Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.42K	Buy	18 +16	+800%	+$4.83K	﹤0.01%	2268
2026 Q1	$662	Sell	2 -150	-99%	-$51K	﹤0.01%	2607
2025 Q4	$60.4K	Sell	152 -228	-60%	-$101K	﹤0.01%	1231
2025 Q3	$173K	Buy	380 +378	+18,900%	+$154K	0.01%	847
2025 Q2	$652	Hold	2	–	–	﹤0.01%	2475
2025 Q1	$540	Buy	+2	New	+$514	﹤0.01%	2667
2024 Q4	–	Sell	-2	Closed	-$550	–	2855
2024 Q3	$550	Hold	2	–	–	﹤0.01%	2352
2024 Q2	$486	Hold	2	–	–	﹤0.01%	1450
2024 Q1	$299	Buy	+2	New	+$334	﹤0.01%	2374
2022 Q4	$475	Buy	+2	New	+$427	﹤0.01%	2176

Other funds holding ALNY

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Laurie J. Hall Trustee $322M AUM 33.73% 1-Year Est. Return

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return